Varsity Healthcare Partners

The three managing partners — David Alpern, Kent Berkley, and Justin Hand — share investment decision authority. They co-founded the firm in 2014 and sit on the investment committee alongside select senior advisors from the operating group. No single partner holds unilateral approval power, enforcing consensus on every platform investment.

VHP relies heavily on its operating-partner network, which includes former CEOs and divisional presidents from scaled healthcare companies who cultivate relationships with founders years before a sale process begins. The firm also works through specialized healthcare investment banks and accounting firms that serve owner-operators in sub-$10M EBITDA businesses, a segment where broad auction processes are less common.

VHP is a pure healthcare services specialist. Since its 2014 founding, the firm has not invested outside outsourced provider, pharma, and payer services. It explicitly avoids clinical practices, life sciences, medical devices, and any business model dependent on direct third-party reimbursement, making it among the most narrowly scoped lower-middle-market buyout firms.

VHP invests exclusively through direct control equity positions, typically using its institutional commingled fund vehicles. The firm does not operate a fund-of-funds program, nor does it pursue minority co-investments alongside other GPs, maintaining full governance over each portfolio company's strategic direction.

The firm targets buyout and growth recapitalization stages in lower-middle-market companies. It seeks established, cash-flow-positive businesses with founder or entrepreneur owners who want a partner to professionalize operations and build scale, rather than companies needing venture-stage technology risk.

VHP explicitly avoids clinical practice management, life sciences, medical devices, branded pharmaceuticals, and any hospital or physician-facing entity where reimbursement risk from government payers or commercial insurers is a meaningful variable. The firm's thesis depends entirely on outsourced service models that sell to healthcare organizations, not to patients or payers directly.

There is no public evidence of a dedicated VHP foundation or donor-advised fund vehicle. The firm and its partners have made individual and firm-directed contributions to healthcare workforce development and education charities, but these appear to be unstructured and ad hoc rather than administered through a separate philanthropic entity.